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Background: Studies conducted thus far have demonstrated that the malaria vaccine (RTS,S) has a promising safety
profile. Within the context of planning for future vaccine trials and for the purpose of building on previous research
that has been undertaken in sub-Saharan Africa with regard to community perceptions about clinical studies, this
research aimed to explore the community perceptions on the secondary health benefits established by the malaria
vaccine trials (RTS,S Phase 2 and Phase 3) at the Korogwe site in Tanzania.
Methods: An exploratory qualitative study design was used. Participants were recruited from the Korogwe site.
Sampling techniques were purposive and random. A total of five focus group discussions and six in-depth
interviews were conducted. Interview guides with open-ended questions were employed to collect data. Male and
female parents whose infants participated and those whose infants did not participate in the trials, health workers
and community leaders were interviewed. Thematic analysis framework was used to analyse the data.
Results: The activities of a malaria vaccine project appeared to be well known to the community. Respondents had
largely positive views towards the secondary health benefits which have been established by malaria vaccine trials.
The project has led to a massive investment in health care infrastructure and an improvement in health care
services across the study areas. The project was perceived by the community to have established major secondary
health benefits. Misconceptions amongst respondents, especially with regard to blood samples, were also observed
in this study.
Conclusion: Despite some misconceptions with regard to the conduct of malaria vaccine trials, especially on blood
sampling, generally this study observed that most participants were positive about the secondary health benefits
brought about by the malaria vaccine trials in Korogwe.
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reproduction in any medium, provided the orincome countries more vaccines are now available and
more lives are being saved, with a significantly decreased
number of children dying each year due to the increased
immunization coverage [1].
Clinical research plays a vital role in complementing the
overburdened national health delivery system, especially
in rural, resource-poor settings [2]. A malaria vaccine is
among the promising new vaccines that are in the final
stages of research. The development of this vaccine will
save millions of lives, mostly in tropical settings.l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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new tools for controlling the disease are needed to facili-
tate the current renewed commitment for its control or
elimination [3]. Optimal control of malaria disease may
be met through a combination of methods such as
vector control [4], chemotherapy [4] and/or vaccines [4].
The challenge facing current control efforts, however, is
the development of resistance to anti-malarial drugs and
insecticides [4].
The primary health benefits of the malaria vaccine trial
(MVT) refer to the major profits or gains that an indivi-
dual acquires after having been vaccinated with the
malaria vaccine, i.e. the efficacy and effectiveness of the
malaria vaccine [5].
The secondary health benefits of the MVT refer to the
additional benefits that an individual or community
receives due to the presence of a malaria vaccine project
in a certain geographical area. Examples of secondary
health benefits may include: community health educa-
tion by research staff; community access to quality and
free medical care; provision of ambulance services to the
community and provision of transport [5].
Several studies that have been conducted worldwide
on community perception regarding clinical trials
reported different findings. A study done in Papua New
Guinea [6] on “Community response to intermittent pre-
ventive treatment of malaria in infants (IPTi)” reported
that parents of participants in that study commented
that their participation had brought them broader bene-
fits as they travelled less often to the clinic since their
children had been treated and protected by the trial
medicine, and gave them more time for other activities
such as farming. Indeed, mothers commonly enrolled
more than one of their children in the study because of
the benefits obtained from the study. For example, trial
staff were considered to be diligent and caring compared
to government health staff who were rude, slow to deal
with mothers and did not give proper care. One mother
conceded that government health workers were rude
because they have a heavy workload. This study reported
both the primary and secondary benefits of the malaria
drug trial [6]. In addition the IPTi malaria trial was able
to distribute new bed nets to all participants in the trial.
The provision of a bed net was perceived by the com-
munity as a secondary health benefit established by the
IPTi trial [6].
A study done in Malawi [2] on “Why mothers choose
to enrol their children in malaria clinical studies and
involvement of relatives in decision making”, reported
that the majority of respondents joined the intermittent
prevention therapy post-discharge (IPTpd) malaria
research due to the secondary health benefits, such as
access to quality medical care, rather than the investiga-
tive aspects of the research. They also decided to enroltheir children in order to benefit from the material and
monetary incentives which included soap, peanut butter,
orange drink, transport money, napkins, mosquito nets,
basins and iron tablets that were being given to partici-
pants by the project.
Another study in Kilifi on the Kenyan coast [7] on
“Community understanding and perceptions of a
malaria vaccine trial (MVT)” reported that the trial was
generally described as some form of assistance, as a
project aimed at ensuring good health in children
through prevention, treatment and check-ups. This was
also true for those who apparently understood the
research aims of the trial. Linked to this finding, the
main reasons for joining and staying in the study were
reported by most to be the individual benefits associ-
ated with the study, such as free treatment, transport to
and from Kilifi District Hospital in case of any illness
and access to the Principal Investigator (PI), who is
medically qualified.
Lusingu, the Principal Investigator of the current phase
3 MVT in Korogwe, reported during an interview with
“one blog” that MVTs have led to a massive investment in
health infrastructure in the communities where vaccine
trials have been implemented. For example, a fully
equipped modern laboratory that specializes in parasito-
logy, haematology, biochemistry and microbiology has
been built in the study area (Korogwe) and is now fully
functional. Vaccine ‘cold chain,’ X-ray services, paediatric
care and referral systems have all been enhanced in the
study area. Important health services have also been pro-
vided to both participants and non-participants in the trial
and community members’ compliance with treatment and
attitudes toward health-seeking behaviour have improved
[8]. This personal interview in Korogwe reported the
secondary health benefits of the MVT but focused
only on the provider perceptions and not community
perceptions. This MVT has been able to employ more
than one hundred staff, who have different levels of
training ranging from secondary education to masters
level.
Understanding community perceptions on the secon-
dary health benefits of this MVT is crucial and the find-
ings of this study will add to the body of knowledge
already available in the literature by highlighting the
secondary health benefits of the MVT in the commu-
nity, which may prompt active community involvement
in future clinical trials.
Results from this study will provide additional evi-
dence to relevant stakeholders, such as malaria vaccine
manufactures, sponsors and policy makers to guide
MVTs, particularly in Tanzania and throughout Africa.
This paper reports the community perceptions on the
secondary health benefits established by the MVT in the
Korogwe site, Tanzania.
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Study design and area
A qualitative study design was chosen to explore the
community perceptions on the secondary health benefits
established by the MVTs in the Korogwe site, Tanzania.
This study was conducted between April and May 2012
and was conducted in the communities involved in the
phase 2 and 3 RTS,S MVTs. Korogwe site is located in
north-eastern Tanzania. This research centre started to
conduct research in 2000 and since then a wide range of
biomedical research has been done. The population of
Korogwe district according to the 2002 Tanzania
National Census Survey was 261,004, with a growth rate
of 1.4% per annum. The district has 47 Government
dispensaries, fivr health centres and two hospitals. The
RTS,S phase 2 and phase 3 MVTs have built nine
vaccination clinics across the study area in Korogwe
District, which covers 34 study villages. Korogwe District
can be topographically stratified into lowland and high-
land zones, with altitudes ranging from 300–1,200
metres above sea level. Malaria transmission in these
areas decreases with increasing altitude and varies within
a short distance. In both zones, malaria transmission is
highest during and following the long rainy season,
which usually extends from March through July.
The first MVT in Korogwe was RTS,S phase 2 which
was conducted between 2006 and 2008. This phase 2
study was conducted in 17 villages which were served by
three satellite vaccination clinics and the paediatric ward
at Korogwe District Hospital (KDH). The RTS,S phase 3
MVT started in 2010; this study operated in 34 villages
in Korogwe and Handeni Districts, including the previ-
ous 17 villages involved in phase 2, and they were also
served by nine vaccination clinics and KDH.
Study population
The study population included parents or caretakers of
children below five years of age registered in the MVT
database and key informants in the study area. Partici-
pants who were selected to take part in this study were
caretakers at the Korogwe site who had been there during
the implementation of the phase 2 and phase 3 MVTs.
Respondents were 18 years and above and were able to
give consent. Participants were excluded if they were away
from the study area during the interview period and if
they were seriously sick during the interview.
Sampling techniques and Data collection methods
A random selection technique was used to select villages
and study participants for focus group discussions
(FGDs) from an already existing study database. Purpo-
sive sampling technique was used to select participants
for in-depth interviews (IDIs). Of 34 villages that partici-
pated in the MVT, only five were randomly selectedusing the Excel function known as “randomize between”
to sample participants for FGDs. Although this is a
qualitative study, random selection technique was used
to select participants because of the availability of a huge
census database with all the information on all 34 study
villages. From the list of potential participants from five
randomly selected villages, those who did not participate
in the MVT were entered differently in Excel. Each list
was again sorted to differentiate between female and male
participants. Thereafter, the Excel function “randomize
between” was used to produce 12 female and male partici-
pants from the MVT respectively in the two different lists.
The same procedure was done for those who did not
participate in the MVT and produced 12 participants. The
purposive technique was used to select six key informants
to participate in IDIs. The criteria for selection were
people from the Korogwe site who were knowledgeable
about the study topic. The selected participants included
two health workers who had observed the activities of
MVTs since 2006, so they had sufficient knowledge about
the topic, and the four other participants were village
leaders who were involved during the sensitization meet-
ings prior to the implementation of the study.
FGDs and IDIs with key informants were used to col-
lect data. Before the interview, demographic information
on participants was collected and subject numbers were
given to participants chronologically.
Conducting focus group discussions and In-depth
interview
FGDs were used to obtain information about community
members’ perceptions on the secondary health benefits
of MVTs. After randomization of participants a day
before the interview, the PI travelled to the respective
villages and, with the help of the community leader,
identified the participants and invited them to attend the
meeting. The venues for the FGDs were organized with
assistance from local village leaders in each village. Prior
to the discussion, the importance of participating in the
study was explained and participants were given informed
consent forms (ICF) to sign. Impartial witnesses were used
for those deemed illiterate. A copy of their signed ICF was
offered to each participant.
Each FGD comprised eight to eleven participants. All
FGDs were conducted in a ‘round table’ manner in the
participants’ respective villages. The PI facilitated the FGDs
while the research assistant experienced in qualitative note
taking took notes. The interview guide was used with
flexibility during the FGDs.
The PI was keen to probe for more information in order
to bring to life the discussions amongst participants. This
process continued until participants were satisfied they
had no further points to add. The PI stopped the interview
and thanked the participants for their participation. After
Liheluka et al. Malaria Journal 2013, 12:157 Page 4 of 9
http://www.malariajournal.com/content/12/1/157each interview, the facilitator and note taker expanded the
notes before moving to another group in order to observe
what information was missing or contradictory, so that
this could be incorporated in the next FGDs. Two FGDs
were conducted per day in each village.
One IDI with a key informant took 33 to 51 minutes.
Interview guides with open-ended questions were pre-
pared and the PI asked the questions as per the guide.
IDIs were conducted in a private setting convenient to the
participants. FGDs were conducted before IDIs in order to
get an overview of the subject matter before interviewing
key informants. Information gathered during the FGDs
was incorporated into the IDI guide and was explored
further during the IDIs.
Data process and analysis
Data was analysed manually using thematic analysis frame-
work. According to Braun and Clarke [9], thematic analysis
framework has six main steps, namely familiarization of
the data, generating initial codes, searching for themes,
reviewing themes, defining and naming themes and produ-
cing the report. For the sake of capitalizing on validity and
reliability, all collected information in the field was given a
code for confidentiality. The triangulation method was
used to collect data. The PI, with the help of the note
taker, read the notes and expanded them before moving to
another group, in order to examine what information was
missing so that it could be incorporated in to the next
FGD. The field notes were read regularly during and after
discussions in order to confirm that all points discussed
had been noted accurately. The narratives were read
and coded by an experienced independent researcher
from Kilimanjaro Christian Medical University College
(KCMUC), themes were then compared, discussed and
agreed upon together with the PI.
Ethical approval
Ethical clearance was granted by Kilimanjaro Christian
Medical University College Ethics Committee with clear-
ance number 456. A letter from the Regional Adminis-
trative Secretary was presented to the administration in
the study district. All participants in the IDIs and FGDs
received information about the research and about the
voluntary nature of the research, both verbally and in
writing, before signing a consent form to comply with
the regulations of the Tanzania National Health Research
Forum.
Results presentation
Descriptive indicators [10] were used to present the
findings of the study. The following explanations detail
how the results are presented in percentages: all (100%
of respondents); nearly all (80-90% of respondents); a
majority (more than 50% of respondents); fewer thanhalf (around 25-45% of respondents); a minority (10-25%
of respondents) and a few (less than 10% of respondents).
“A” represents participants in the FGDs and “B” repre-
sents participants in the IDIs. Subject numbers were
given to participants chronologically.Results
Demographic characteristics of study participants
Of a total of 55 participants, 49 participated in the FGDs
and six participated in IDIs; all were male. Most par-
ticipants resided in rural areas. Among respondents,
small-scale farming and small businesses were common
occupations. Those with formal employment included
MDs and VEOs. Respondents’ ages ranged from 21 to 71
years.
Participants had an overall positive view towards the
secondary health benefits established by MVTs. The main
themes that emerged from this study were: i) improve-
ment of health care services; ii) transport; iii) infrastruc-
ture and iv) human resources. Misconceptions were also
reported by a minority of participantsImprovement of health care services
All participants agreed that the phase 2 and phase 3
RTS,S MVTs improved the quality of health care to the
study participants, as well as the community as a whole,
by providing reliable, full-time and quick medical care.
The participants claimed that the project had improved
health care services at the hospital level where a modern
laboratory and radiology unit had been built in the
compound of Korogwe District Hospital. The presence
of these facilities offered better health care to study
participants, as well as to the whole community. One
36-year-old male health worker explained that:
“We have a big laboratory which has been built by the
malaria project through donors’ fund, for this
laboratory to be in the District Hospital compound, it
has given us (the District Hospital) the opportunity to
utilize the structure, human resources as well as the
services and because of the poor quality of most of the
government laboratories, the presence of this
laboratory which is also monitored and overseen by
the laboratory professionals and experts from abroad,
it has helped us so much to have the quality
laboratory services in the District” (Participant
number B55)
Participants who did not get an opportunity to partici-
pate in the MVT expressed their willingness to participate
in the project because of the quality health care services
offered by the project. A 42-year-old female who did not
participate in the trials explained that:
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project are really praising the project; I want also to
join the project because of the good health services
which are being offered by the project such as free
medical care…” (Participant number A3)
Some participants who participated in the FGDs but
who did not participate in the trials were not aware
of the health care services being offered by the
project.
The majority of respondents, including those who
participated in the MVT and those who did not, stated
that the project has been able to reduce the number of
deaths for children under five in the study area due to
the effective and fast treatment offered to trial partici-
pants as well as non-participants. A 36-year-old male
health worker explained:
“The death of children has been massively reduced in
the paediatric ward” (Participant number B5)
Some respondents who participated in the FGDs but
who did not participate in the MVTs, were quiet about
this subtheme, likely because they were not knowledgeable
about the topic.
The majority of the participants, especially women in
the FGDs, reported that the malaria vaccine project
provided treated mosquito nets to all participants.
However, there were concerns about the number of nets
provided by the project, which was perceived to be
limited. A minority of the participants did not comment
on this subtheme. One 59-year-old female commented
that:
“…If possible we request that each participant in the
malaria vaccine project should get more than one bed
net in order to prevent other children in the family…”
(Participant number A09)
In addition to distribution of bed nets, most participants
mentioned close follow up and monitoring of participants
by the project health workers as an important component
of the project. A 53-year-old male participant stated:
“…Participants in the malaria vaccine project are
being followed by the project field workers to monitor
their health status…” (Participant number A19)
Nearly all respondents expressed that the malaria vac-
cine project provided very good care to trial participants.
Project staff use polite language and provide good care
to participants and non-participants. However there are
some malaria vaccine staff who are rude. A 43-year-old
female stated:“…Majority of malaria vaccine staff are very polite
and caring. However there are some staff who are
rude. One day my children were sick, I went to
Magunga Hospital (Magunga is the name of
Korogwe District Hospital) I was so embarrassed by
one doctor. I am not sure whether he is the project
employee or the government employee but I thank
God some malaria vaccine staff assisted me…”
(Participant number A06)
The majority of respondents, especially in the FGDs,
expressed that in case of death of any of the study
participants the malaria vaccine project does parti-
cipate in the funeral. Participants commented that the
project always provides condolences and transport for
caretakers of the study participants in case of any
death. A 59-year-old male respondent commented
that:
“…Malaria vaccine project do provide transport and
condolences to the caretakers in case of any death of
the study participants…” (Participant number A13)
All participants in both FGDs and IDIs explained that
the malaria vaccine project provides free treatment to
the community and especially to those trial participants.
Free treatment is perceived by respondents as one of the
primary benefits established by MVTs. One 48-year-old
female commented:
“…Even if the parents or guardians do not have money
they still get quality health service, this project does
not segregate between rich people and poor people…”
(Participant number A45)
The majority of the respondents in both FGDs and
IDIs explained that the malaria vaccine project has
established a referral system for participants who cannot
be treated at the project dispensary or at Korogwe
District Hospital. This particular theme was discussed by
respondents in both FGDs and IDIs. Respondents
expressed that once the study participant is seriously
sick and he/she cannot be treated at the health facility
across the study area, the patient is referred immediately
to a referral hospital for further check up and treatment.
The community perceived this as a vital secondary
health benefit brought by the malaria vaccine project. A
43-year-old female explained:
“…One day my child had a foreign body ingestion
(chicken bone) he couldn’t be treated at Korogwe
District Hospital. The project referred my child to
KCMC Referral Hospital and he was well treated and
is doing very fine now” (Participant number A06)
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Overall, the majority of participants in all FGDs and IDIs
stated that the availability of transport is one of the
major secondary health benefits brought by the project.
Most participants explained that project vehicles provide
free transport to study participants, as well as non-study
participants. As one 59-year-old male stated:
“…Malaria vaccine project provide free transport to
the people…” (Participant number A26)
A few respondents were quiet on the above topic,
maybe because they were not involved directly in the
research or because they stayed closer to the project
dispensary. Fewer participants, especially in the IDIs,
expressed that the project collaborated well with the
District Hospital in case of emergencies. A 36-year-old
male health worker explained:
“…For example last year during the national
vaccination campaign malaria project has given us the
vehicle and driver. They really assisted the Hospital.
We are very grateful for the collaboration which exists
between the project and the Hospital…” (Participant
number B55)
The majority of respondents, especially in the FGDs,
were not conversant with the collaboration between the
project and the District Hospital because they were not
involved directly in the day-to-day activities of the
project as well as the District Hospital.
Human resources
A few participants, especially in the IDIs, explained that
the project has massively increased the number of health
professionals across the study area. Respondents claimed
that the project employed qualified staff from different
parts of the country as well as from outside the country.
A 36-year-old male health worker commented:
“…There are project staff who are working in the
paediatric ward and radiology unit; they really assist
to bridge the gap of the shortage of human resources
which we are facing in this hospital…” (Participant
number B55)
Another 36-year-old male health worker explained:
“…If I can recall correctly we came here in 2006, in
Korogwe District Hospital there was no medical doctor
but MVT has been able to employ three qualified
medical doctors and 12 nursing officers who are
working in the paediatric ward” (Participant
number B54)A few respondents, especially in the IDIs, expressed
that the project had been able to provide employment
chances to people in the community across the study
area. Respondents explained that the community appre-
ciates the contribution of the project for employing
people from the community and they perceive this
contribution as one of the major secondary health bene-
fits that has been established by the malaria project. A
36-year-old male health worker claimed:
“…The presence of malaria vaccine project has assisted
the community members to get some auxiliary
employment, I have seen some young people employed
by the project, although they don’t have good
education but these young people could have been
bad people in the community but due to the
presence of the malaria vaccine project these young
people have managed to get employment…”
(Participant number B55)
The majority of respondents, especially in the FGDs,
were not conversant with the two subthemes above,
perhaps because they were not closely involved in the
health systems. Key informants had sufficient informa-
tion about the topics.
Infrastructure
A few participants, especially in the IDIs, explained that
the project had built nine vaccination centres in the
study area and the modern laboratory, which is fully
equipped with both modern equipment and qualified
staff. Respondents elaborated that the presence of health
care facilities across the study area has brought health
care services close to the community, which is perceived
by the community as one of the most important secon-
dary health benefits established by the malaria vaccine
project. A 36-year-old male health worker explained:
“…The community has been able to get health care
services closer to the areas in which they live. In our
community it is normal to find the distance between
one household and the health facility is too far but the
project has managed to build dispensaries closer to the
communities which facilitate easier provision of health
services…” (Participant number B55 in the IDI
number 06)
The same respondent continued:
“…Also malaria vaccine project has been able to
renovate our dispensaries and they have built some
new structures for vaccination of their study subjects.
Our dispensaries were in bad condition and old but
the project has assisted to renovate. At Korogwe
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modern laboratory…” (Participant number B55)
The majority of respondents, especially in the FGDs,
were not familiar with the above subtheme. They were
not sure whether the infrastructure had been built by
the government or by the project.
Misconceptions
A few respondents raised some questions with regard to
the trial activities, especially on blood sampling; for
example, some respondents claimed that there were
reports that the blood collected from participants was
sold by the research institute; and others stated that the
blood is used for satanic purposes (Mumiani- Kiswahili
word which means blood-suckers). Those respondents
claimed that people with less experience of research,
such as the elderly and residents of remote villages, were
believed to have spread such rumours.
“…The amount of blood which is taken is high, so people
are scared; they need to be educated. They said the
project is selling the blood…” (Participant number A33)
After further exploration, the majority of the respon-
dents reported that the blood is used for diagnostic
purposes especially for malaria disease.Discussion
This study found that the RTS,S MVTs had several sec-
ondary health benefits as perceived by community. The
trials have improved health care services, either directly
or indirectly, for the study communities. Respondents
explained that since the establishment of the project, the
communities involved in the malaria research are
pleased with the health care services that are offered by
the malaria project. This is not a surprising finding as it
is well documented that in a situation of poor service
delivery, as in most less-developed countries, medical
care in a research setting is described in more favourable
terms [2].
Additionally, participants observed that most project
staff are polite and caring compared to those working in
other health care systems. This observation could be due
to the fact that most staff employed by the project are
well motivated by continuous training, which they
receive on ethical issues and on patient health care. On
the other hand, health care workers working in other
health care systems, such as in government health
facilities and faith-based organizations (FBOs), may be
perceived to be rude due to a heavy workload, poor
working conditions, or a lack of training in patient
health care provider relationships. It is well documentedthat politeness and caring towards patients by health
care providers are very crucial in delivering quality
health services [6,11]. These observations underline the
importance of training of all health care providers on
patient-centred care to improve the quality of health
care [12].
This study found that the community perceived the
number of deaths of children under five, especially those
children participating in the MVTs, had been reduced
across the study area. This may be due to the close
follow up of young children and prompt attention when
need arises by the study staff.
The findings of this study reveal excessive appreciation
for the malaria project from the respondents with regard
to health care services being offered to the communities
by the project. This could be due to lack of trial know-
ledge among community members because the most com-
monly provided benefits were medical care (for example
free care), and tea or soft drinks while waiting to see a
physician. All cash given to participants was reimburse-
ment of transport costs (for example to meet appoint-
ments or facilitate use of services when unexpectedly
sick), but these payments were often described by research
participants as benefits because communities had been
receiving poor health care services from other existing
health care systems in the country before and even during
the implementation of the malaria project. Sometimes it
was surprising to learn that the community would like the
malaria project to be permanent because of the services
offered by the project. This observation should be an alert
to other health care systems to improve health care
services to poor, rural communities. Similar findings have
been reported by Masiye et al., 2008 in Malawi, which
reported that a majority of respondents wished to join the
project due to the secondary health benefits offered by the
project, including soap and transport fare.
Another significant finding in this study is that the
trials employed competent health staff and increased the
number of health care professionals in the study area. In
vaccine trials it is important to employ sufficient staff
for the effective implementation of the project. Staff
have been employed to work for the malaria vaccine
project but they also work for the community surroun-
ding the study area. Availability of health staff employed
by the project has been a big boost to the government
health facilities, which were overloaded by routine health
care activities. This calls for the government to put into
place strategies to absorb the additional workforce once
the project is over.
The perceived improvement in health care services is
similar to the findings from studies in Kenya and Papua
New Guinea (6,7) respectively, which reported that the
projects were able to improve health care services for
trial participants.
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malaria vaccine projects have managed to build new
structures and renovate some old buildings across the
study area in order to facilitate trial activities.
The presence of health care facilities and other health
care investments across the study area has put health care
services closer to the community, which is perceived by
the community as one of the most important secondary
health benefits established by the malaria vaccine project.
The government of Tanzania has a policy of building
health facilities a maximum 5 km from people, but this is
not the case in the Korogwe site because there are villages
within the study area which are 15 km from a dispensary.
In addition, the study revealed that there were some
misconceptions about MVTs, and particularly rumours
regarding blood samples. Some community members
were hesitant to participate in the malaria project due to
rumours associated with claims that blood was sold by
the research institution. This was a misconception and
showed a lack of knowledge among community mem-
bers with regard to research activities. Blood was only
used for research purposes and the amount of blood
taken considered the health of the participant. However,
after further exploration most participants knew that
blood samples were used for diagnosis purposes. This
particular finding should remind researchers to consider
conducting regular sensitization meetings in study com-
munities throughout the study period in order to educate
the community about the trial. Community advisory
boards (CABs) are effective ways for studies to communi-
cate with the community and will help to clear miscon-
ceptions, which, if ignored, will be likely to affect future
community participation in clinical trials.
Other studies [2,6,13-15] also reported that participants
raised concerns with regard to blood samples. Some
community members thought the blood was taken for
business and/or satanic purposes. After further explo-
ration, however, the majority of people were aware that
the blood was taken for research purposes.
Conclusion
The study findings showed community appreciation of the
secondary health benefits established by the trials in the
Korogwe site. The project has led to a massive investment
in the health care infrastructure and improvement of
health care services across the study area, which was
perceived by the community as a major secondary health
benefit established by the project. Health care services
provided by the project were perceived to be good com-
pared to the government health facilities and FBOs. The
project has also been able to increase the workforce in the
government health facilities by employing qualified staff
working for both trial participants and the community at
large. A misconception among respondents, especiallywith regard to blood samples, was also observed in this
study. Sensitization meetings should be regularly con-
ducted by researchers in order to avoid misconceptions in
future studies.
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